Larry Biegelsen
Stock Analyst at Wells Fargo
(3.77)
# 2,013
Out of 4,983 analysts
1342
Total ratings
50.3%
Success rate
3.3%
Average return
Main Sectors:
Stocks Rated by Larry Biegelsen
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SYK Stryker | Rated: Buy | $348 | $280.13 | +24.23% | 41 | Sep 16, 2026 | |
| AXGN Axogen | Reiterated: Buy | $48 | $45.29 | +6.00% | 3 | Sep 11, 2026 | |
| COO The Cooper Companies | Reiterated: Hold | $66 → $61 | $53.78 | +13.44% | 45 | Sep 9, 2026 | |
| DXCM DexCom | Reiterated: Buy | $90 | $87.93 | +2.35% | 64 | Sep 9, 2026 | |
| MDT Medtronic | Reiterated: Buy | $104 | $92.77 | +12.11% | 91 | Sep 9, 2026 | |
| ABT Abbott Laboratories | Reiterated: Buy | $112 | $102.23 | +9.56% | 115 | Sep 8, 2026 | |
| ENOV Enovis | Reiterated: Buy | $33 | $17.80 | +85.39% | 6 | Sep 8, 2026 | |
| MMED MiniMed Group | Reiterated: Buy | $26 | $22.03 | +18.02% | 5 | Sep 8, 2026 | |
| GEHC GE HealthCare Technologies | Rated: Buy | $85 | $64.45 | +31.90% | 29 | Aug 25, 2026 | |
| HTFL HeartFlow | Rated: Buy | $37 → $39 | $49.57 | -21.32% | 4 | Aug 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $16 | $8.42 | +90.02% | 5 | Aug 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $19 | $14.15 | +34.28% | 13 | Aug 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $103 → $99 | $74.16 | +33.50% | 13 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $9 | $5.32 | +69.17% | 26 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $90 → $103 | $94.25 | +9.28% | 43 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $28 → $14 | $10.28 | +36.19% | 2 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $255 → $144 | $141.55 | +1.73% | 40 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $56 | $72.74 | -23.01% | 39 | Aug 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $272 → $282 | $270.22 | +4.36% | 99 | Aug 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $374 | $318.87 | +17.29% | 48 | Aug 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $74 → $83 | $85.57 | -3.00% | 43 | Jul 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $39 → $46 | $46.13 | -0.28% | 3 | Jul 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $138 → $178 | $161.42 | +10.27% | 56 | Jul 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $15 → $18 | $15.10 | +19.21% | 14 | Jul 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $55 → $50 | $43.55 | +14.81% | 51 | Jul 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $487 | $383.54 | +26.98% | 61 | Jul 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $28 | $24.35 | +14.99% | 6 | Jul 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $21 → $27 | $17.23 | +56.70% | 31 | Jun 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $70 | $87.53 | -20.03% | 3 | May 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $116 → $138 | $125.59 | +9.88% | 20 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $14 → $17 | $16.72 | +1.67% | 43 | May 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | CHF 71.84 → CHF 79.18 | CHF 53.44 | +48.17% | 33 | Feb 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $80 → $84 | $126.33 | -33.51% | 3 | Feb 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $17 → $18 | $16.77 | +7.33% | 57 | Feb 19, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $96 → $100 | $88.25 | +13.31% | 65 | Feb 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $184 → $157 | $181.38 | -13.44% | 40 | Feb 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $280 → $270 | $228.42 | +18.20% | 2 | Jan 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $24 → $19 | $23.02 | -17.46% | 36 | Dec 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $3 | $1.98 | +51.52% | 22 | Nov 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.7728 | - | 15 | Oct 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $26 → $20 | $100.80 | n/a | 3 | Aug 2, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $15 → $1.4 | $10.50 | n/a | 3 | Sep 26, 2013 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | n/a | $140.92 | n/a | 1 | Jan 4, 2010 |
Stryker
Sep 16, 2026
Rated: Buy
Price Target: $348
Current: $280.13
Upside: +24.23%
Axogen
Sep 11, 2026
Reiterated: Buy
Price Target: $48
Current: $45.29
Upside: +6.00%
The Cooper Companies
Sep 9, 2026
Reiterated: Hold
Price Target: $66 → $61
Current: $53.78
Upside: +13.44%
DexCom
Sep 9, 2026
Reiterated: Buy
Price Target: $90
Current: $87.93
Upside: +2.35%
Medtronic
Sep 9, 2026
Reiterated: Buy
Price Target: $104
Current: $92.77
Upside: +12.11%
Abbott Laboratories
Sep 8, 2026
Reiterated: Buy
Price Target: $112
Current: $102.23
Upside: +9.56%
Enovis
Sep 8, 2026
Reiterated: Buy
Price Target: $33
Current: $17.80
Upside: +85.39%
MiniMed Group
Sep 8, 2026
Reiterated: Buy
Price Target: $26
Current: $22.03
Upside: +18.02%
GE HealthCare Technologies
Aug 25, 2026
Rated: Buy
Price Target: $85
Current: $64.45
Upside: +31.90%
HeartFlow
Aug 14, 2026
Rated: Buy
Price Target: $37 → $39
Current: $49.57
Upside: -21.32%
Aug 13, 2026
Reiterated: Buy
Price Target: $16
Current: $8.42
Upside: +90.02%
Aug 12, 2026
Rated: Buy
Price Target: $19
Current: $14.15
Upside: +34.28%
Aug 7, 2026
Reiterated: Buy
Price Target: $103 → $99
Current: $74.16
Upside: +33.50%
Aug 6, 2026
Reiterated: Hold
Price Target: $9
Current: $5.32
Upside: +69.17%
Aug 6, 2026
Rated: Hold
Price Target: $90 → $103
Current: $94.25
Upside: +9.28%
Aug 5, 2026
Reiterated: Buy
Price Target: $28 → $14
Current: $10.28
Upside: +36.19%
Aug 5, 2026
Downgraded: Hold
Price Target: $255 → $144
Current: $141.55
Upside: +1.73%
Aug 4, 2026
Reiterated: Hold
Price Target: $56
Current: $72.74
Upside: -23.01%
Aug 3, 2026
Reiterated: Buy
Price Target: $272 → $282
Current: $270.22
Upside: +4.36%
Aug 3, 2026
Reiterated: Hold
Price Target: $374
Current: $318.87
Upside: +17.29%
Jul 31, 2026
Rated: Hold
Price Target: $74 → $83
Current: $85.57
Upside: -3.00%
Jul 30, 2026
Reiterated: Hold
Price Target: $39 → $46
Current: $46.13
Upside: -0.28%
Jul 30, 2026
Rated: Buy
Price Target: $138 → $178
Current: $161.42
Upside: +10.27%
Jul 30, 2026
Reiterated: Hold
Price Target: $15 → $18
Current: $15.10
Upside: +19.21%
Jul 29, 2026
Reiterated: Hold
Price Target: $55 → $50
Current: $43.55
Upside: +14.81%
Jul 23, 2026
Reiterated: Buy
Price Target: $487
Current: $383.54
Upside: +26.98%
Jul 15, 2026
Rated: Buy
Price Target: $28
Current: $24.35
Upside: +14.99%
Jun 1, 2026
Upgraded: Buy
Price Target: $21 → $27
Current: $17.23
Upside: +56.70%
May 22, 2026
Reiterated: Hold
Price Target: $70
Current: $87.53
Upside: -20.03%
May 8, 2026
Reiterated: Hold
Price Target: $116 → $138
Current: $125.59
Upside: +9.88%
May 4, 2026
Rated: Hold
Price Target: $14 → $17
Current: $16.72
Upside: +1.67%
Feb 26, 2026
Upgraded: Buy
Price Target: CHF 71.84 → CHF 79.18
Current: CHF 53.44
Upside: +48.17%
Feb 20, 2026
Reiterated: Hold
Price Target: $80 → $84
Current: $126.33
Upside: -33.51%
Feb 19, 2026
Reiterated: Hold
Price Target: $17 → $18
Current: $16.77
Upside: +7.33%
Feb 11, 2026
Reiterated: Buy
Price Target: $96 → $100
Current: $88.25
Upside: +13.31%
Feb 10, 2026
Reiterated: Hold
Price Target: $184 → $157
Current: $181.38
Upside: -13.44%
Jan 30, 2026
Reiterated: Hold
Price Target: $280 → $270
Current: $228.42
Upside: +18.20%
Dec 12, 2025
Reiterated: Hold
Price Target: $24 → $19
Current: $23.02
Upside: -17.46%
Nov 13, 2025
Reiterated: Hold
Price Target: $3
Current: $1.98
Upside: +51.52%
Oct 21, 2025
Rated: Hold
Price Target: n/a
Current: $0.7728
Upside: -
Aug 2, 2018
Reiterated: Buy
Price Target: $26 → $20
Current: $100.80
Upside: n/a
Sep 26, 2013
Downgraded: Hold
Price Target: $15 → $1.4
Current: $10.50
Upside: n/a
Jan 4, 2010
Upgraded: Buy
Price Target: n/a
Current: $140.92
Upside: n/a